Form D · Biotechnology

VBI VACCINES INC.

Cambridge, MA · CIK 0000704159

Offering snapshot reported Aug 26, 2015 · SEC filing

Reported sold
$6.29M
Offering amount: $6.29M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 13, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 26, 2015Initial$6,285,700No comparison19SEC filing
Aug 8, 2014Initial$36,356,807No comparison27SEC filing
Aug 8, 2014Initial$11,000,000No comparison6SEC filing
Feb 12, 2014Initial$250,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-246473

Source: Form D, filed Aug 26, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Anderson Executive
Jeff Baxter Director, Executive
Adam T. Buckley Executive
T. Adam Buckley Executive
Sam Chawla Director
Trent Davis Director
Michel De Wilde Director
Steve Gillis Director
Marc Kirchmeier Executive
Egidio Nascimento Executive
Charles L.F. Paulson Director
Chester L.F. Paulson Promoter
Shannon P. Pratt, D.B.A. Director
Paul F. Shoen Director
Murray G. Smith Executive
Michael Steinmetz Director
Alan Timmins Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
222 Third Street Suite 2241
Cambridge, MA, 02142